Research reportRoles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice
Introduction
Kainic acid (KA), the analog of the excitatory amino acid l-glutamate, is a neuroexcitatory and neurotoxic substance. KA, upon binding to non-N-methyl-d-aspartate (non-NMDA) glutamate receptors, causes depolarization of neurons followed by severe status epilepticus, neurodegeneration, plasticity, memory loss and neuronal damage in the mammalian central nervous system, especially the hippocampal formation. [1], [3], [12], [14], [17], [27], [29], [41], [44], [51].
The phosphorylated extracellular signal-regulated kinase (p-ERK) is increased by systemic administration of KA in the rat hippocampus [15], [26]. Seizures induce the sprouting of mossy fibers in the CA3 region of rat hippocampus [4]. We have also demonstrated p-ERK immunoreactivity (IR) is increased in the mouse hippocampus by KA administered intracerebroventricularly (i.c.v.) [23]. The activation of ERK protein has been reported to be important in determining whether a cell survives or undergoes apoptosis [49], and also in activating transcription factors [46].
KA leads to the induction of several types of proto-oncogene products, such as Jun and Fos proteins, which serve as the third messengers in the hippocampus [17], [47]. Administration of KA at convulsant dose also induces the expression of c-Fos, Fos-related antigen 1 (Fra-1), Fos-related antigen 2 (Fra-2) and Jun in rat and mouse hippocampus [18], [22], [30], [35], [38], [50]. The increased expression of c-Fos and c-Jun induced by KA might be a maker in seizure activity, excitotoxicity or the activation of target genes [19], [42], [48].
The activation of microglia can be detected using an activated microglial marker, the complement receptor type 3 (OX-42) IR. It is known that KA applied to CA3 region causes selective pyramidal cell death and activates microglial cells [7], [32].
It has been reported that adenosine release is evoked by KA and adenosine is a powerful anticonvulsant substance [5], [13]. An increase of hippocampal adenosine release and metabolism is associated with seizure activity and the increased adenosine may attenuate seizure activity [5], [11], [34]. Adenosine modulates neuronal activity and neurotransmitter release through interacting with their receptors. Adenosine blocks synaptic transmission by attenuating neurotransmitter release. For example, adenosine enhances the inhibitory action of tetrodotoxin on nerve conduction [40]. Ochiishi et al. [31] have investigated the possible changes of adenosine A1 receptors expression in kainate-treated rats and found that A1 receptors are distributed in the CA2 and CA3 field in the normal rat hippocampus. The mRNA expression of adenosine A2a receptors is distributed in the hippocampus CA1, CA3, dentate gyrus (DG) and cerebral cortex, mainly localized in the pyramidal and granular cells; the same hippocampal regions shows adenosine A1 receptor mRNA expression [10]. GABA release is depressed by A2a receptor activation in the hippocampus [9]. It has been accepted that adenosine shows neuroprotective and neurotoxic roles in the CNS. A1 receptors are known to exert the protective action against hippocampal neuronal death induced by KA epileptic preconditioning or sublethal global ischemia [37]. However, the role of A2 receptors in the regulation of cell death induced by KA administered intracerebroventriculary (i.c.v.) in mice has not been characterized. Furthermore, the cellular mechanism of A2 receptors involved in KA-induced neurotoxicity has not yet been well elucidated. Thus, the effects of adenosine receptor antagonists on KA-induced hippocampal cell death and expression of several signal molecules such as p-ERK, c-Jun, c-Fos, Fra-1, Fra-2 and OX-42 were examined in the present study.
Section snippets
Methods
These experiments were approved by the University of Hallym Animal Care and Use Committee. All procedures were conducted in accordance with the ‘Guide for Care and Use of Laboratory Animals’ published by the National Institutes of Health. All efforts were made to minimize animal suffering and to reduce the number of animals used.
Effects of DMPX and PACPX on KA-induced cell death in CA3 region of the hippocampus
We have examined cell death in hippocampus using the cresyl violet staining. The cresyl violet staining was performed with samples perfused 1 day after i.c.v. KA administration. As shown in Fig. 1, in our morphological study, the neuronal death induced by i.c.v. administered KA (0.1 μg) in hippocampus was conspicuously concentrated on the CA3 pyramidal neurons. No cell death was observed in any other regions (data not shown). The number of cells in the CA3 regions was about 200 and this number
Discussion
In mice, systemic injection of KA produces a marked loss of neuronal layers in the pyramidal CA1 and CA3 regions [19]. By comparison, in the rat hippocampus, the neuronal morphological injury induced by systemic injection of KA occurs most markedly in the CA1 region [42], while the pyramidal cells of CA3 region remain intact. I.c.v. KA administration, however, was associated with both immediate (day 1) and delayed (day 14) neuronal loss in the rat dorsal hippocampus. The immediate injury was
Acknowledgments
This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (01-PJ1-PG3-21400-0035).
References (52)
- et al.
Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus
Brain Research
(1999) - et al.
Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system
Neuroscience
(1993) - et al.
Kainate, a double agent that generates seizures: two decades of progress
Trends in Neurosciences
(2000) - et al.
Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats
Brain Research
(2000) - et al.
Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not—melatonin counteracts the effects of ischaemia and kainite
Brain Research
(1997) - et al.
Hippocampal damage induced by ischemia and intra-amygdaloid kainate injection: effect on N-methyl-d-aspartate, N-(1-[2-thienyl]cyclohexyl)piperidine and glycine binding sites
Neuroscience
(1989) - et al.
Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia?
Biological Psychiatry
(1998) - et al.
Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals
Neuropharmacology
(2000) - et al.
Evidence for functionally important adenosine A2a receptors in the rat hippocampus
Brain Research
(1994) - et al.
Modulation of memory processing by glutamic acid receptor agonists and antagonists
Brain Research
(1990)
Loss of A1 adenosine receptors in human temporal lobe epilepsy
Brain Research
Different hippocampal molecular requirements for short- and long-term retrieval of one-trial avoidance learning
Behavioural Brain Research
Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2a receptor antagonist
Brain Research
Sustained potentiation of AP1 DNA binding is not always associated with neuronal death following systemic administration of kainic acid in murine hippocampus
Neurochemistry International
Microglia: a sensor for pathological events in CNS
Trends in Neurosciences
Intracerebroventricular injections in mice. Some methodological refinements
Journal of Pharmacological and Toxicological Methods
Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus
Neuroscience Letters
Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice
Molecules and Cells
Differential expression and phosphorylation of particular fos family members by kainate in nuclear and cytosolic fractions of murine hippocampus
Neuroscience
Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures
Neuroscience
High level of adenosine A1 receptor-like immunoreactivity in the CA2/CA3a region of the adult rat hippocampus
Neuroscience
The fate of synaptic receptors in the kainate-lesioned striatum
Brain Research
The anticonvulsant properties of antisense c-fos oligodeoxynucleotides in kainic acid-induced seizures
Journal of the Neurological Sciences
Effects of kainic acidinduced seizures and ischemia on c-fos-like proteins in rat brain
Brain Research
Learning about kainate receptors
Trends in Pharmacological Sciences
Kainic acid induced seizures: neurochemical and histopathological changes
Neuroscience
Cited by (18)
Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling
2020, Brain ResearchCitation Excerpt :Contrariwise, in chronic Epilepsy there is an increase of the density and function of A2AR (Barros-Barbosa et al., 2016; Canas et al., 2018; Rebola et al., 2005), an effect observed in glutamatergic synapses accompanied by an increase in glutamate release (Canas et al., 2018), where glutamate-mediated excitotoxicity becomes a trigger of neurodegeneration (Canas et al., 2018; Cunha, 2016). Thus, the blockade of A2AR, either using genetic deletion of A2AR or selective A2AR antagonists administration can prevent neuronal damage following convulsions (Canas et al., 2018; Rosim et al., 2011), supporting a key role of A2AR in the control of neurodegeneration after a convulsive episode (Canas et al., 2018; Cunha, 2016; Lee et al., 2004; Rosim et al., 2011). Thus, the use of non-selective agonists (NECA) as adjunctive therapy for the control of Drug Resistant Epilepsy presents advantages by having an anticonvulsive effect per se by delaying the evolution of convulsions, as well as by modulating the efflux transporters protein levels (P-GP/MRPs), which results in the facilitation of the delivery of drugs such as CBZ to the brain and therefore the restoration of its anticonvulsant effect.
Neuronal vs Glial Cell Contribution to Adenosine A2A Receptor-Induced Neurodegeneration
2017, Adenosine Receptors in Neurodegenerative DiseasesDifferential neuroprotection by A <inf>1</inf> receptor activation and A <inf>2A</inf> receptor inhibition following pilocarpine-induced status epilepticus
2011, Epilepsy and BehaviorCitation Excerpt :These results are not in line with several reports employing different noxious brain stimuli that demonstrated the ability of A2A receptor blockade to confer neuroprotection [14,25,36–38]. Some authors used A2A receptor antagonists in the kainic acid model of neurotoxicity [39,40] or in a model of cerebral ischemia [31] and reported robust neuroprotection, particularly in the areas (i.e., cortex) where the density of these receptors is much lower than in basal ganglia [41–43]. In fact, A2A receptors can be upregulated during prolonged seizures and this response is most evident in extrastriatal regions (i.e., cortical area) [24].
Glutamate differently modulates excitatory and inhibitory adenosine receptors in neuronal and glial cells
2010, Neurochemistry InternationalAdenosine A<inf>1</inf> receptors are crucial in keeping an epileptic focus localized
2006, Experimental Neurology